Literature DB >> 3921051

Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase.

J D Stanger, J L Yovich.   

Abstract

A series of 62 women were managed in the University of Western Australia/PIVET Laboratory in-vitro fertilization programme. In 60 of them follicle growth was stimulated with clomiphene citrate with or without additional human menopausal gonadotrophin (hMG) and in two with hMG alone. Follicles were aspirated at laparoscopy following an hCG trigger injection and occasionally following a spontaneous luteinizing hormone (LH) surge. Oocytes were inseminated with 0.5 X 10(5)-10(5) sperm/ml 3-6 h later. A significant reduction (P less than 0.001) in the fertilization rate of mature oocytes was observed in those patients whose basal serum LH values were greater than 1 SD above the mean. Fifty-nine women subsequently had embryo transfer and of 10 clinical pregnancies, none occurred in those with elevated LH values. Reduced fertilization may be a reflection of premature oocyte maturation or ageing. This may have clinical implications in the management of some patients with unexplained infertility.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3921051     DOI: 10.1111/j.1471-0528.1985.tb01113.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  48 in total

1.  A case report: successful pregnancy after controlled ovarian hyperstimulation by using short-acting gonadotropin releasing hormone agonist only.

Authors:  Fei Gong; Sufen Cai; Shunji Zhang; Changfu Lu; Ge Lin; Guangxiu Lu
Journal:  J Assist Reprod Genet       Date:  2012-02-09       Impact factor: 3.412

2.  Recurrent miscarriage.

Authors:  L Regan
Journal:  BMJ       Date:  1991-03-09

3.  Exogenous luteinizing hormone (LH) increases estradiol response patterns in poor responders with low serum LH concentrations.

Authors:  J Y Phelps; L Figueira-Armada; A S Levine; N P Vlahos; D Roshanfekr; H A Zacur; J E Garcia
Journal:  J Assist Reprod Genet       Date:  1999-08       Impact factor: 3.412

4.  "Premature luteinization" in the era of GnRH analogue protocols: time to reconsider.

Authors:  Johnny S Younis
Journal:  J Assist Reprod Genet       Date:  2011-05-26       Impact factor: 3.412

Review 5.  The significance of high follicular-phase luteinizing hormone levels in the treatment of women with polycystic ovarian syndrome by in vitro fertilization.

Authors:  B C Tarlatzis; G Grimbizis
Journal:  J Assist Reprod Genet       Date:  1997-01       Impact factor: 3.412

6.  The uses of LH-releasing hormone and analogs in infertility.

Authors:  R Fleming; C Conaghan; J R Coutts
Journal:  Ir J Med Sci       Date:  1986-12       Impact factor: 1.568

7.  The impact of high progesterone levels in the follicular phase of in vitro fertilization (IVF) cycles: a comparative study.

Authors:  D Feldberg; G A Goldman; J Ashkenazi; D Dicker; M Shelef; J A Goldman
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-02

8.  A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program.

Authors:  N O Turhan; P G Artini; G D'Ambrogio; F Droghini; C Battaglia; A D Genazzani; A Volpe; A R Genazzani
Journal:  J Assist Reprod Genet       Date:  1993-01       Impact factor: 3.412

9.  Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial.

Authors:  K Clifford; R Rai; H Watson; S Franks; L Regan
Journal:  BMJ       Date:  1996-06-15

10.  Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist Cetrorelix at different dosages.

Authors:  R Felberbaum; T Reissmann; W Küpker; S Al-Hasani; O Bauer; T Schill; C Zoll; C Diedrich; K Diedrich
Journal:  J Assist Reprod Genet       Date:  1996-03       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.